| David J Ridley, MD | |
|
2854 Highway 55 Ste 190, Eagan, MN 55121-1783 | |
| (651) 644-4277 | |
| (651) 644-4018 |
| Full Name | David J Ridley |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 46 Years |
| Location | 2854 Highway 55 Ste 190, Eagan, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659396000 | NPI | - | NPPES |
| 585090800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 26149 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Paul Rheumatology P A | 0941264741 | 3 |
News Archive
For years, anecdotal evidence suggested that ovulating or pregnant women or post-menopausal women taking estrogen supplements, experienced fewer asthma attacks and less severe asthma symptoms, strongly suggesting that perhaps estrogen affects airway smooth muscle function by preventing the hyperresponsiveness characteristic of asthma and other chronic lung diseases.
A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.
Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.
A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
› Verified 3 days ago
| Entity Name | St Paul Rheumatology P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053344788 PECOS PAC ID: 0941264741 Enrollment ID: O20041111001060 |
News Archive
For years, anecdotal evidence suggested that ovulating or pregnant women or post-menopausal women taking estrogen supplements, experienced fewer asthma attacks and less severe asthma symptoms, strongly suggesting that perhaps estrogen affects airway smooth muscle function by preventing the hyperresponsiveness characteristic of asthma and other chronic lung diseases.
A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.
Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.
A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David J Ridley, MD 2854 Highway 55 Ste 130, Eagan, MN 55121-1776 Ph: (651) 224-4930 | David J Ridley, MD 2854 Highway 55 Ste 190, Eagan, MN 55121-1783 Ph: (651) 644-4277 |
News Archive
For years, anecdotal evidence suggested that ovulating or pregnant women or post-menopausal women taking estrogen supplements, experienced fewer asthma attacks and less severe asthma symptoms, strongly suggesting that perhaps estrogen affects airway smooth muscle function by preventing the hyperresponsiveness characteristic of asthma and other chronic lung diseases.
A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.
Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.
A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
› Verified 3 days ago
Dr. Paul Anthony Karazija, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3400 Yankee Dr, R416, Eagan, MN 55121 Phone: 651-662-2566 | |
Laurie Jepson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3305 Central Park Village Dr Ste 200, Eagan, MN 55121 Phone: 651-406-8860 Fax: 651-688-7864 | |
Sajan Jiv Singh Nagpal, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 205, Eagan, MN 55123 Phone: 612-871-1145 Fax: 612-870-5491 | |
Ashish K Tiwari, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 205, Eagan, MN 55123 Phone: 612-871-1145 Fax: 612-870-5491 | |
Sarah Mcintire, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8860 | |
Erin Elizabeth Mccarville, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8880 | |
Janine Pingel, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8880 |